Scarica l'app Stockscreener
63.12
0.86%
-0.55
Pre-mercato:
63.25
0.13
+0.21%
Precedente Chiudi:
$63.67
Aprire:
$63.28
Volume 24 ore:
900.20K
Relative Volume:
0.59
Capitalizzazione di mercato:
$3.27B
Reddito:
$412.82M
Utile/perdita netta:
$-8.19M
Rapporto P/E:
-409.60
EPS:
-0.1541
Flusso di cassa netto:
$64.17M
1 W Prestazione:
-1.05%
1M Prestazione:
+25.59%
6M Prestazione:
+275.04%
1 anno Prestazione:
+334.41%
Intervallo 1D:
$0.00
$0.00
Intervallo di 1 settimana:
$61.19
$65.13
Portata 52W:
$13.95
$72.51
Caredx Inc Stock (CDNA) Company Profile
Nome
Caredx Inc
Settore
Industria
Telefono
415-287-2300
Indirizzo
8000 MARINA BLVD, BRISBANE, CA
Compare CDNA vs TMO, DHR, NTRA, A, IQV
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CDNA
Caredx Inc
|
63.12 | 3.27B | 412.82M | -8.19M | 64.17M | -0.1541 |
TMO
Thermo Fisher Scientific Inc
|
662.24 | 244.86B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
221.20 | 155.50B | 24.78B | 3.68B | 5.29B | 5.1743 |
NTRA
Natera Inc
|
397.77 | 57.34B | 2.50B | -226.32M | 71.51M | -1.6412 |
A
Agilent Technologies Inc
|
171.33 | 48.30B | 7.23B | 1.41B | 1.09B | 4.979 |
IQV
Iqvia Holdings Inc
|
262.21 | 43.16B | 16.63B | 1.39B | 2.12B | 8.0674 |
Caredx Inc Stock (CDNA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-09-02 | Iniziato | Canaccord Genuity | Buy |
| 2026-08-03 | Aggiornamento | Craig Hallum | Hold → Buy |
| 2026-01-06 | Downgrade | Craig Hallum | Buy → Hold |
| 2025-08-26 | Iniziato | William Blair | Mkt Perform |
| 2025-01-15 | Aggiornamento | Wells Fargo | Underweight → Equal Weight |
| 2024-08-28 | Iniziato | Wells Fargo | Underweight |
| 2024-08-19 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2024-05-13 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2024-05-01 | Aggiornamento | Craig Hallum | Hold → Buy |
| 2023-11-09 | Aggiornamento | Stephens | Equal-Weight → Overweight |
| 2023-08-15 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2023-05-11 | Downgrade | BTIG Research | Buy → Neutral |
| 2023-03-07 | Downgrade | Stephens | Overweight → Equal-Weight |
| 2023-03-03 | Downgrade | Craig Hallum | Buy → Hold |
| 2023-03-03 | Downgrade | Raymond James | Strong Buy → Mkt Perform |
| 2022-04-25 | Iniziato | Stephens | Overweight |
| 2021-07-20 | Ripresa | BTIG Research | Buy |
| 2021-06-03 | Iniziato | Goldman | Buy |
| 2021-02-26 | Downgrade | H.C. Wainwright | Buy → Neutral |
| 2020-10-30 | Reiterato | H.C. Wainwright | Buy |
| 2020-10-08 | Reiterato | H.C. Wainwright | Buy |
| 2020-10-02 | Reiterato | H.C. Wainwright | Buy |
| 2020-08-05 | Reiterato | H.C. Wainwright | Buy |
| 2020-06-26 | Iniziato | BTIG Research | Buy |
| 2020-06-19 | Reiterato | H.C. Wainwright | Buy |
| 2019-10-01 | Ripresa | Craig Hallum | Buy |
| 2019-05-09 | Aggiornamento | H.C. Wainwright | Neutral → Buy |
| 2019-02-15 | Iniziato | Jefferies | Buy |
| 2018-10-23 | Ripresa | Raymond James | Strong Buy |
| 2018-09-18 | Reiterato | H.C. Wainwright | Neutral |
| 2017-11-27 | Iniziato | H.C. Wainwright | Buy |
| 2016-06-14 | Reiterato | Mizuho | Buy |
| 2015-09-29 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2015-09-25 | Iniziato | Craig Hallum | Buy |
| 2015-03-18 | Reiterato | Mizuho | Buy |
Mostra tutto
Caredx Inc Borsa (CDNA) Ultime notizie
A Look at CareDx Inc (CDNA) After 4.0% Gain -- GF Value $25.50 v - GuruFocus
Form 4 Caredx Inc For: 5 October By Investing.com - Investing.com South Africa
CareDx General Counsel Reports Withholding of Shares for RSU Tax Obligations - Kalkine Media
CareDx CEO John Walter Withholds 8,511 Shares for Tax on RSU Vesting - Kalkine Media
Stock vesting triggers 997-share tax withholding for CareDx (CDNA) counsel Jeffrey Adam Novack. - Stock Titan
CareDx CCO Jessica Meng Withholds 2,619 Shares for RSU Tax on October 1, 2026 - Kalkine Media
After 8,511 shares were withheld for taxes, CareDx (CDNA) CEO holds 644,937 shares directly. - Stock Titan
Tax withholding leaves CareDx (CDNA) CFO Keith Kennedy with 208,686 directly held shares. - Stock Titan
For stock-vesting taxes, CareDx (CDNA) withholds 2,619 shares from its chief commercial officer. - Stock Titan
A 588-share grant replaces cash pay for CareDx (CDNA) director Michael Goldberg. - Stock Titan
Immunogenomics Market Size, Share, Trends, and Growth Forecast, 2026-2033 | NGS and Personalized Medicine Drive Market Toward USD 9.82 Billion at 5.97% CAGR - GlobeNewswire Inc.
Biotech Stocks At 52-Week HighsCDNA, RCEL, AZTA, HNGE - RTTNews
CareDx, Inc (CDNA) stock price, news, quote and history - Yahoo Finance UK
Caredx Inc stock hits 52-week high at 65.53 USD - Investing.com
Caredx Inc stock hits 52-week high at 65.53 USD By Investing.com - Investing.com Canada
Caredx Inc stock hits 52-week high at 65.53 USD By Investing.com - Investing.com UK
Consumer Confidence Falls Amid Ongoing Geopolitical Tensions: 4 Picks - Zacks Investment Research
Consumer Confidence Falls Amid Ongoing Geopolitical Tensions: 4 Picks - es.tradingview.com
CareDx, Inc. (CDNA) Stock Price, News, Quote & History - Yahoo! Finance Canada
CareDx Refocused On Transplant Testing, And Wall Street Noticed - Finimize
CareDx, Inc. (CDNA) stock price, news, quote and history - Yahoo Finance Singapore
CareDx: I Was Wrong, But The Rally Has Outrun The Fundamentals (Rating Upgrade) - Seeking Alpha
CareDx (CDNA) Stock Jumps 13.0%: Will It Continue to Soar? - Yahoo Finance
CareDx Inc (CDNA) Stock Up 13.0% but GF Value Says Overvalued -- GF Score: 66/100 - gurufocus.com
CareDx +14% on Fresh $74 Analyst Price Target - Yahoo Finance
BTIG raises CareDx stock price target to $74 on transplant outlook - Investing.com
Zacks.com featured highlights include CareDx, Ciena, Celestica, Materion and MACOM Technology Solutions - Yahoo Finance
Medicare Lab Fee Changes Impact BillionToOne, CareDx Differently - Benzinga
A Look at CareDx Inc (CDNA) After 4.0% Gain -- GF Value $25.41 v - gurufocus.com
Caredx Inc stock hits 52-week high at 55.21 USD - Investing.com
CAREDX INC (NASDAQ:CDNA): High Growth and Improving Fundamentals Fuel Bullish Case - ChartMill
CareDx, Inc. (CDNA) Investor Outlook: Riding High with a 52.20% Revenue Growth in the Healthcare Sector - DirectorsTalk Interviews
CareDx (CDNA) CFO uses 8,220 shares to cover RSU taxes - Stock Titan
Caredx Inc stock hits 52-week high at 53.71 USD - Investing.com
CareDx (NASDAQ: CDNA) CCO has 6,688 shares withheld for taxes - Stock Titan
CareDx (NASDAQ:CDNA) Meets Minervini Trend Template with High-Growth Momentum - ChartMill
Oil Surge Continues on Escalating Middle East Crisis: 4 Defensive Picks - TradingView
Are Medical Stocks Lagging CareDx (CDNA) This Year? - Yahoo Finance
Technical Reactions to CDNA Trends in Macro Strategies - Stock Traders Daily
CareDx (NASDAQ:CDNA) Screens Well on High Growth Momentum and Breakout Setup - ChartMill
CDNA Initiates Coverage by Canaccord Genuity -- Price Target Set at $65 - GuruFocus
Canaccord Genuity Initiates Coverage of CareDx, BillionToOne With Buy Ratings - GenomeWeb
Canaccord initiates CareDx stock coverage with buy rating on testing By Investing.com - Investing.com South Africa
Canaccord initiates CareDx stock coverage with buy rating on testing By Investing.com - Investing.com Nigeria
Canaccord Genuity Initiates CareDx at Buy With $65 Price Target - marketscreener.com
Canaccord initiates CareDx stock coverage with buy rating on testing - Investing.com India
Canaccord initiates CareDx stock coverage with buy rating on testing - investing.com
CareDx (CDNA) is a Great Momentum Stock: Should You Buy? - Eastern Progress
CareDx (CDNA) is a Great Momentum Stock: Should You Buy? - Yahoo Finance
Caredx Inc stock hits 52-week high at 49.77 USD By Investing.com - Investing.com Canada
Caredx Inc Azioni (CDNA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Caredx Inc Azioni (CDNA) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| PETER MAAG | Director |
Aug 14 '26 |
Proposed Sale |
45.30 |
7,000 |
317,113 |
0 |
| PETER MAAG | Director |
Aug 13 '26 |
Proposed Sale |
47.07 |
7,000 |
329,505 |
0 |
| PETER MAAG | Director |
Aug 12 '26 |
Proposed Sale |
46.89 |
7,000 |
328,238 |
0 |
| PETER MAAG | Director |
Aug 11 '26 |
Proposed Sale |
47.69 |
7,000 |
333,851 |
0 |
| PETER MAAG | Director |
Aug 10 '26 |
Proposed Sale |
47.66 |
6,902 |
328,949 |
0 |
| ARTHUR TORRES | Director |
Aug 10 '26 |
Proposed Sale |
47.73 |
4,200 |
200,475 |
0 |
| PETER MAAG | Director |
Aug 07 '26 |
Proposed Sale |
45.83 |
27,332 |
1,252,492 |
0 |
| GEORGE W BICKERSTAFF | Director |
Aug 05 '26 |
Proposed Sale |
46.28 |
20,000 |
925,700 |
0 |
| Bickerstaff George | Director |
Aug 05 '26 |
Sale |
46.28 |
20,000 |
925,700 |
134,061 |
| Novack Jeffrey Adam | Secretary and General Counsel |
Aug 05 '26 |
Sale |
46.26 |
2,688 |
124,349 |
106,075 |
2.68%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):